Literature DB >> 3900084

A macrophage activating factor is present and active in the ascitic fluid of patients with ovarian cancer.

M Kaneko, M Nishida, H Iwasaki.   

Abstract

Morphological and functional changes in human monocytes and peritoneal macrophages from six patients with ovarian cancer were studied. The surface architecture of exudate macrophages from ascitic fluid have already been shown to exhibit extensive spreading and ruffled membranes. Consequently, peripheral monocytes from the patients were cultured with ascitic fluid from the same individuals. They gradually displayed active membrane pseudopodia, thorn-like processes and petal-like ruffles after 2 h to 4 h of cultivation. Adherent peritoneal macrophages from the patients demonstrated increased consumption of glucose. These results suggest a macrophage activating factor (MAF) exists in ascitic fluid in patients with ovarian cancer which plays an initial role in the change of monocytes into macrophages.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3900084     DOI: 10.1007/bf00402726

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  14 in total

1.  Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells.

Authors:  W F Piessens; W H Churchill
Journal:  J Immunol       Date:  1975-01       Impact factor: 5.422

2.  The mechanism of cell surface changes of guinea pig macrophages activated with purified migration inhibitory factor/macrophage activation factor.

Authors:  Y Homma; K Onozaki; Y Fukutomi; T Hashimoto
Journal:  Cell Immunol       Date:  1982-09-15       Impact factor: 4.868

3.  Production of an antibody against guinea pig MIF. III. Biological activity of MIF recovered from immunoadsorbent column chromatography.

Authors:  K Onozaki; S Haga; M Ichikawa; Y Homma; K Miura; T Hashimoto
Journal:  Cell Immunol       Date:  1981-06       Impact factor: 4.868

Review 4.  In vitro approaches to the mechanism of cell-mediated immune reactions.

Authors:  B R Bloom
Journal:  Adv Immunol       Date:  1971       Impact factor: 3.543

5.  Activation in vitro of mouse macrophages by syngeneic, allogeneic, or xenogeneic lymphocyte supernatants.

Authors:  I J Fidler
Journal:  J Natl Cancer Inst       Date:  1975-11       Impact factor: 13.506

6.  Lack of responsiveness of C3H/HeJ macrophages to lipopolysaccharide: the cellular basis of LPS-stimulated metabolism.

Authors:  J L Ryan; L M Glode; D L Rosenstreich
Journal:  J Immunol       Date:  1979-03       Impact factor: 5.422

7.  Cytotoxicity of human macrophages for tumor cells. Enhancement by human lymphocyte mediators.

Authors:  D J Cameron; W H Churchill
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

8.  Scanning electron microscopy of murine macrophages. Surface characteristics during maturation, activation, and phagocytosis.

Authors:  A Polliack; S Gordon
Journal:  Lab Invest       Date:  1975-11       Impact factor: 5.662

9.  Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.

Authors:  G Poste; R Kirsh; W E Fogler; I J Fidler
Journal:  Cancer Res       Date:  1979-03       Impact factor: 12.701

10.  Changes in cellular enzyme levels and extracellular release of lysosomal acid hydrolases in macrophages exposed to group A streptococcal cell wall substance.

Authors:  P Davies; R C Page; A C Allison
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

View more
  2 in total

1.  Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity.

Authors:  Peter C Hart; Preety Bajwa; Hilary A Kenny
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Glycation of calmodulin binding domain of iNOS may increase the chance of occurrence of tuberculosis in chronic diabetic state.

Authors:  Rajasri Bhattacharyya; Dibyajyoti Banerjee
Journal:  Bioinformation       Date:  2011-12-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.